Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

被引：228

作者：

Yu, Fei ^{[1
]}

Du, Lanying ^{[2
]}

Ojcius, David M. ^{[3
]}

Pan, Chungen ^{[4
]}

Jiang, Shibo ^{[2
,5
]}

机构：

[1] Hebei Agr Univ, Coll Life & Sci, Baoding, Peoples R China

[2] New York Blood Ctr, Lindsley Kimball Res Inst, New York, NY 10021 USA

[3] Univ Pacific, Sch Dent, Dept Biomed Sci, San Francisco, CA 94115 USA

[4] Guangdong Haid Grp Co Ltd, Haid Res Inst, Guangdong Haid Inst Anim Husb & Vet, Guangzhou, Peoples R China

[5] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China

来源：

MICROBES AND INFECTION | 2020年 / 22卷 / 02期

关键词：

2019-nCoV; Diagnosis; Preventive; Therapeutic; EAST RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; HUMAN MONOCLONAL-ANTIBODIES; SPIKE PROTEIN; SARS-COV; MERS-COV; NEUTRALIZING ANTIBODY; POSTEXPOSURE EFFICACY; CROSS-NEUTRALIZATION; FUNCTIONAL RECEPTOR;

D O I：

10.1016/j.micinf.2020.01.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO). As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries. Therefore, combating this new virus and stopping the epidemic is a matter of urgency. Here, we focus on advances in research and development of fast diagnosis methods, as well as potential prophylactics and therapeutics to prevent or treat 2019-nCoV infection. (C) 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

引用

页码：74 / 79

页数：6

共 72 条

[1] Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]
[2] Investigation of Anti-Middle East Respiratory Syndrome Antibodies in Blood Donors and Slaughterhouse Workers in Jeddah and Makkah, Saudi Arabia, Fall 2012
Aburizaiza, Asad S.
Mattes, Frank M.
Azhar, Esam I.
Hassan, Ahmed M.
Memish, Ziad A.
Muth, Doreen
Meyer, Benjamin
Lattwein, Erik
Mueller, Marcel A.
Drosten, Christian
[J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (02) : 243 - 246
[3] Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Agrawal, Anurodh Shankar
Tao, Xinrong
Algaissi, Abdullah
Garron, Tania
Narayanan, Krishna
Peng, Bi-Hung
Couch, Robert B.
Tseng, Chien-Te K.
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2351 - 2356
[4] [Anonymous], EMERG MICROB INFECT
[5] Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants
Bakker, ABH
Marissen, WE
Kramer, RA
Rice, AB
Weldon, WC
Niezgoda, M
Hanlon, CA
Thijsse, S
Backus, HHJ
de Kruif, J
Dietzschold, B
Rupprecht, CE
Goudsmit, J
[J]. JOURNAL OF VIROLOGY, 2005, 79 (14) : 9062 - 9068
[6] Pacing a small cage: mutation and RNA viruses
Belshaw, Robert
Gardner, Andy
RarnbaUt, Andrew
Pybus, Oliver G.
[J]. TRENDS IN ECOLOGY & EVOLUTION, 2008, 23 (04) : 188 - 193
[7] Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
Buchholz, UJ
Bukreyev, A
Yang, LJ
Lamirande, EW
Murphy, BR
Subbarao, K
Collins, PL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9804 - 9809
[8] Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, Jasper F. W.
Chan, Kwok-Hung
Kao, Richard Y. T.
To, Kelvin K. W.
Zheng, Bo-Jian
Li, Clara P. Y.
Li, Patrick T. W.
Dai, Jun
Mok, Florence K. Y.
Chen, Honglin
Hayden, Frederick G.
Yuen, Kwok-Yung
[J]. JOURNAL OF INFECTION, 2013, 67 (06) : 606 - 616
[9] Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
Chan, Kwok-Hung
Chan, Jasper Fuk-Woo
Tse, Herman
Chen, Honglin
Lau, Candy Choi-Yi
Cai, Jian-Piao
Tsang, Alan Ka-Lun
Xiao, Xincai
To, Kelvin Kai-Wang
Lau, Susanna Kar-Pui
Woo, Patrick Chiu-Yat
Zheng, Bo-Jiang
Wang, Ming
Yuen, Kwok-Yung
[J]. JOURNAL OF INFECTION, 2013, 67 (02) : 130 - 140
[10] Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate
Chen, Wen-Hsiang
Du, Lanying
Chag, Shivali M.
Ma, Cuiqing
Tricoche, Nancy
Tao, Xinrong
Seid, Christopher A.
Hudspeth, Elissa M.
Lustigman, Sara
Tseng, Chien-Te K.
Bottazzi, Maria Elena
Hotez, Peter J.
Zhan, Bin
Jiang, Shibo
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (03) : 648 - 658

← 1 2 3 4 5 6 7 8 →